PPT Slide
Celltech desires to take advantage of the “Safe Harbor” provisions of the US Private
Securities Litigation Reform Act of 1995, with respect to forward looking statements contained
within this document. In particular certain statements with regard to, management’s
strategic vision, aims and objectives, the conduct of clinical trials, the filing dates for
product licence applications and the anticipated launch of specified products in various
markets, anticipated levels of demand for existing products and products in development, the
effect of competition, anticipated efficiencies, planned divestments or investments, trends in
results of operations, margins, the overall pharmaceutical market and exchange rates, are all
forward looking in nature. By their nature forward looking statements involve risks and
uncertainties that could cause actual results to differ materially from those expressed
or implied by the forward looking statements. Although not exhaustive, the following factors could cause actual results to differ materially from those the Company expects: difficulties inherent in the discovery and development of new products and the design and implementation of pre-clinical and clinical studies, trials and investigations, results from such studies, trials and investigations that are inconsistent with previous results and the Company’s expectations, the failure to obtain and maintain required regulatory approvals, product and pricing initiatives by the Company’s competitors, inability of the Company to market existing and new products effectively and the failure of the Company’s strategic partners to perform their obligations. Other factors that could affect these forward looking statements are described in the Company’s reports filed with the US Securities and Exchange Commission. The forward looking statements included in this document represent the Company’s best judgement as of the date hereof based in part on preliminary information and certain assumptions which management believes to be reasonable. The Company disclaims any obligation to update these forward looking statements.